Acuvax Limited (ACU, formerly Avantogen Limited) is a
pharmaceutical company developing and commercialising drugs
and nutraceuticals in the oncology and vaccine markets. The
company has investments in Hawaii Biotech Inc (34%),
Avantogen Oncology Inc (43%), and RESprotect GnbH (10%).